Y16
25 mg
| Purity Not Available
TargetMol
Y16 is a G-protein–coupled Rho GEFs inhibitor; works synergistically with Rhosin/G04 in inhibiting LARG-RhoA interaction, RhoA activation, and RhoA-mediated signaling functions.
More Information
Supplier Page
Y16
2 mg
| Purity Not Available
TargetMol
Y16 is a G-protein–coupled Rho GEFs inhibitor; works synergistically with Rhosin/G04 in inhibiting LARG-RhoA interaction, RhoA activation, and RhoA-mediated signaling functions.
More Information
Supplier Page
TargetMol
Salubrinal, a phosphatases (PP1) inhibitor(IC50=1.7 μM), exhibits function on the eukaryotic translation initiation factor 2 subunit (eIF2α).
More Information
Supplier Page
TargetMol
D-(+)-Melezitose hydrate (melicitose) is a nonreducing trisaccharide sugar that is produced by many plant sap-eating insects, including aphids such as Cinara pilicornis by an enzyme reaction.
More Information
Supplier Page
TargetMol
Olaparib is a small molecule inhibitor of PARP1/PARP2 (IC50: 5/1 nM) but is less effective against the PARP tankyrase-1 (IC50: 1.5 μM).
More Information
Supplier Page
TargetMol
Olaparib is a small molecule inhibitor of PARP1/PARP2 (IC50: 5/1 nM) but is less effective against the PARP tankyrase-1 (IC50: 1.5 μM).
More Information
Supplier Page
TargetMol
Spermine is a biogenic polyamine formed from spermidine. It is found in a wide variety of organisms and tissues and is an essential growth factor in some bacteria.
More Information
Supplier Page
TargetMol
TargetMol
1-piperoylpiperidine, (E,E)-, a alkaloid, has been used in trials studying the treatment of multiple myeloma and deglutition disorders.
More Information
Supplier Page
ALK-IN-1
25 mg
| Purity Not Available
TargetMol
ALK-IN-1 (AP26113) is a potent ALK inhibitor with IC50 of 0.62 nM in a cell-free assay, demonstrated ability overcome Crizotinib resistance mediated by a L1196M mutation. Phase 2.
More Information
Supplier Page